I. Zachrisson et al., Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys, GROWTH H I, 10(6), 2000, pp. 324-331
Hyperglycaemia and increased variability of blood glucose in pubertal child
ren with type 1 diabetes may be related to increased growth hormone (GH) se
cretion and insulin resistance. The role of changes in insulin-like growth
factor-I (IGF-I) bioavailability for the glycaemic control in these patient
s has not been completely elucidated. In particular, the possible role of i
ncreased IGF binding protein-3 (IGFBP-3) proteolysis reported in other insu
lin resistant states awaits further characterization. The aims of this stud
y were to assess if hyperglycaemia in children with type 1 diabetes was ass
ociated with changes in free dissociable IGF-I (fdIGF-I) and IGF binding pr
otein-3 protease activity (IGFBP-3-PA) and if increased insulin resistance
during puberty was associated with changes in IGFBP-3-PA in healthy and dia
betic children. In diabetic boys in the period of maximal linear growth (Ta
nner stage 3, n = 5), the mean level and the variability of IGFBP-3-PA, det
ermined every second hour throughout 24 h, were significantly higher both c
ompared to postpubertal diabetic boys (n = 6; P = 0.003 and P = 0.001, resp
ectively), and to age matched healthy boys (n = 4; P = 0.006 and P <0.001 r
espectively). This activation of IGFBP-3-PA was most prominent during the d
aytime. The mean 24 h blood glucose level (determined hourly) was the only
parameter studied that significantly predicted the changes in mean 24 h IGF
BP-3-PA in the diabetes group. The mean 24 h concentrations of fdIGF-I were
decreased in the diabetic boys compared to the healthy controls but statis
tical significance was only achieved in Tanner Stage 5 (P = 0.03). We specu
late that the elevated levels of IGFBP-3-PA in Tanner 3 diabetic boys are r
elated to deteriorated glucose homeostasis and that it may be a compensator
y mechanism to attenuate the decrease in fdIGF-I in order to partly restore
insulin sensitivity and glycemic control. (C) 2000 Harcourt Publishers Ltd
.